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Total knee arthroplasty (TKA) is a cost-effective 
means to treat end-stage knee arthritis. The annual 
number of TKAs has been increasing worldwide. 
Various means have been used to reduce blood 
loss and the incidence of blood transfusion during 
TKA.1,2 In TKA patients, the predictors of the need 
for blood transfusion are preoperative haemoglobin 
level, intra-operative blood loss, and post-operative 
drain output.3 The use of tranexamic acid has gained 
popularity, partly attributable to the advocacy of fast 
track surgery. 
 In this issue, Goyal et al.4 compared the early 
clinical outcome in patients who underwent primary 
TKA with the use of intra-articular TXA. The authors 
reported a lower transfusion rate and shorter hospital 
stay in the TXA than control group. The total cost 
saving with regard to the reduced blood transfusion 
was AU$144 per patient. Combined with the 
shortened hospital stay, the total saving was AU$631 
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per patient. Nonetheless, there is no consensus on the 
optimal regimen of TXA in TKA. Intravenous, intra-
articular, oral, and combined administrations have 
been reported to achieve satisfactory outcome.5–8 The 
decision depends on the surgeon’s preference and the 
cost. Although there are concerns about systemic use 
of TXA in increasing the risk of hypercoagulation and 
thromboembolic events, it was safe to use in most 
patients.
 It is worth pointing out that the study by Goyal 
et al.4 was a retrospective review of medical records. 
The TXA group was compared with the historical 
controls. The preoperative diagnosis and patients’ 
co-morbidities were not clearly documented. The 
peri-operative care in terms of deep vein thrombosis 
prophylaxis, rehabilitation and discharge protocol 
was not standardised. Therefore, the evidence 
generated is not as strong as that from randomised 
controlled trials or meta-analyses.
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